Xanthine derivatives, and their use in pharmaceutical compositio

Details Xanthine derivatives, and their use in pharmaceutical compositio Xanthine derivatives, and their use in pharmaceutical compositio

1981-06-29

1984-05-29

Rizzo, Nicholas S.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

544267, 544268, C07D23995, A61K 3152

Patent

active

044514492

ABSTRACT:
Ketals of 1-(1,3-dialkylxanthin-7-yl)propan-2-ones are of use in the treatment of vascular disorders. A representative embodiment is 2-methyl-2-(1,3-dibutylxanthin-7-ylmethyl)-1,3-dioxalane.

REFERENCES:
patent: 3737433 (1973-06-01), Mohler et al.
CA, vol. 72, 21697j, (1970).
CA, vol. 94, 167711k, (1981).

Affiliated with

Also associated with

Rating

Xanthine derivatives, and their use in pharmaceutical compositio does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Xanthine derivatives, and their use in pharmaceutical compositio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine derivatives, and their use in pharmaceutical compositio will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1396877